Reframe Wealth’s Johnson & Johnson JNJ Stock Holding History

Reframe Wealth’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$876K	Buy	+4,959	New	+$856K	0.34%	25

Other funds holding JNJ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Reframe Wealth's JNJ Position: Q4 2022 in Review

Reframe Wealth opened a new position in Johnson & Johnson (JNJ) in Q4 2022: 4,959 shares worth $876K. The stake represents 0.34% of the portfolio and ranks #25 among its holdings.

3,791 funds tracked by Wall St. Rank hold JNJ as of Q4 2022.

Reframe Wealth held 4,959 shares of Johnson & Johnson worth $876K as of Q4 2022.
Johnson & Johnson was a new Reframe Wealth position in Q4 2022.
Johnson & Johnson made up 0.34% of Reframe Wealth's portfolio in Q4 2022, its #25 holding.
3,791 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2022.

Based on Reframe Wealth's 13F filing for Q4 2022, filed 30 Mar 2023.